Endocrine therapy for postmenopausal women with hormone receptor-positive her2-negative advanced breast cancer after progression or recurrence on nonsteroidal aromatase inhibitor therapy: a Canadian consensus statement

Endocrine therapy for postmenopausal women with hormone receptor-positive her2-negative advanced breast cancer after progression or recurrence on nonsteroidal aromatase inhibitor therapy: a Canadian consensus statement

Item
http://www.wikidata.org/entity/Q36568571
Delaying Chemotherapy in the Treatment of Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast CancerManagement of patients with hormone receptor-positive breast cancer with visceral disease: challenges and treatment optionsReview of hormone-based treatments in postmenopausal patients with advanced breast cancer focusing on aromatase inhibitors and fulvestrantClinical practice guidelines and consensus statements in oncology--an assessment of their methodological quality.EPMA position paper in cancer: current overview and future perspectives.Treatment Considerations for the Management of Patients With Hormone Receptor-Positive Metastatic Breast Cancer.Everolimus plus exemestane as first-line therapy in HR⁺, HER2⁻ advanced breast cancer in BOLERO-2.The Estrogen Receptors: An Overview from Different Perspectives.Enhancing Endocrine Therapy Combination Strategies for the Treatment of Postmenopausal HR+/HER2- Advanced Breast Cancer.Real-world effectiveness of everolimus-based therapy versus fulvestrant monotherapy in HR(+)/HER2(-) metastatic breast cancer.Aromatase inhibitors in premenopausal women with breast cancer: the state of the art and future prospects.
P2860

Endocrine therapy for postmenopausal women with hormone receptor-positive her2-negative advanced breast cancer after progression or recurrence on nonsteroidal aromatase inhibitor therapy: a Canadian consensus statement

Item
http://www.wikidata.org/entity/Q36568571
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Endocrine therapy for postmeno ...... a Canadian consensus statement
@ast
Endocrine therapy for postmeno ...... a Canadian consensus statement
@en
type
label
Endocrine therapy for postmeno ...... a Canadian consensus statement
@ast
Endocrine therapy for postmeno ...... a Canadian consensus statement
@en
prefLabel
Endocrine therapy for postmeno ...... a Canadian consensus statement
@ast
Endocrine therapy for postmeno ...... a Canadian consensus statement
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P932
P356
P1433
P1476
Endocrine therapy for postmeno ...... a Canadian consensus statement
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P932